Normal embryonic and foetal devlopment depends on the ability of cells to move from one place to another. This behaviour enables cells to be produced at one site and transported to one or a number of other sites. Although the face appears to us as a single seamless unit it originates as a number of blocks of tissue which begin development separately and must grow in a coordinated way that enables them to meet at precisely the correct time, in the correct place and in the correct order. The basis ....Normal embryonic and foetal devlopment depends on the ability of cells to move from one place to another. This behaviour enables cells to be produced at one site and transported to one or a number of other sites. Although the face appears to us as a single seamless unit it originates as a number of blocks of tissue which begin development separately and must grow in a coordinated way that enables them to meet at precisely the correct time, in the correct place and in the correct order. The basis of this growth and fusion is the ability of individual cells to move around the embryo to supply the raw materials for this construction process when and where they are needed. The combined activities of the cells in constructing the various parts of the embryo is known as morphogenesis which literally means creating shape. We are trying to gain insight into the basis of morphogenesis that produces the face. This is important because the face and other structures that are closely associated with it are particularly prone to errors. Despite this, surprisingly little is known about the mechansims that control development of the face. We know a great deal about which cells are involved in constructing the face but very little about what triggers the initial steps of development or maintains ordered growth. Our research is aimed at defining genes that are important in controlling development of the face through the study of normal development and birth defects. We are defining the function of genes that appear to be important in controlling the behaviour of cells during early development of the face. This knowledge will assist in understanding the control mechanism for facial devlopment and will eventually lead to improvements in the treatment and prevention of birth defects affecting these structures.Read moreRead less
Regulation Of The Anti-tumour Immune Response By The Chemokine Decoy Receptor CCX-CKR
Funder
National Health and Medical Research Council
Funding Amount
$562,742.00
Summary
Melanoma is a significant cause of cancer-related deaths in Australians. Death is usually due to metastasis of the cancer to the lungs and other organs. In this project, we will take advantage of unique mouse models to determine whether inhibition of the function of a novel protein can prevent melanoma growth and metastasis to different organs. The results of this study may lead to new therapeutic approaches to control malignant melanoma and other metastatic cancers.
Evaluation Of Circulating Endothelial Cells In Prostate Cancer Detection, Prognosis And Treatment Response
Funder
National Health and Medical Research Council
Funding Amount
$32,628.00
Summary
A current shortfall in clinical medicine is tests which discriminate different forms and severity of cancers. The project will aim to identify useful strategies based on blood factors of angiogenesis, a fundamental process in tumour growth and dissemination. Development of such tests may permit better delineation of prognosis, act as a surrogate marker of treatment efficacy and aid in developing and optimizing new treatments, key areas of need in prostate cancer.
Dynamics And Mechanisms Of Immune Complex-mediated Skin Inflammation
Funder
National Health and Medical Research Council
Funding Amount
$526,467.00
Summary
Type III hypersensitivity underlies a number of common autoimmune diseases, including rheumatoid arthritis and lupus erythematosus. These diseases are caused by the deposition of immune complexes (IC) and the accumulation of neutrophils within small blood vessels. We will use real time imaging to dissect in space and time the recruitment of neutrophils and IC deposition during type III hypersensitivity reactions in order to better understand the pathogenesis of these conditions.
Investigating Polarity Proteins In Thymocytes- A Potential Role In Asymmetric Cell Division?
Funder
National Health and Medical Research Council
Funding Amount
$69,684.00
Summary
To protect us against infection, surveying immune cells will launch an attack against foreign cells by using complex signalling process to communicate with each other. A novel method in which immune cells differentiate to defend the body against infection has been recently discovered this year and this project will involve dissecting how this occurs. It will involve using state-of-the-art laser-based technologies, combined with studying immune events in cells and intact organs.
Cellular And Molecular Characterization Of Erythroid Enucleation
Funder
National Health and Medical Research Council
Funding Amount
$671,950.00
Summary
A major challenge for transfusion medicine is the constant difficulties in obtaining enough supply of specific red blood cell (RBC) subtypes. In this proposal, we will identify the key steps of enucleation (extrusion of nucleus), a rate limiting process for the in vitro production of RBCs. A better understanding of this process will lead to improved strategies for the efficient and rapid production of self-generated RBCs for individual patient transfusion.
The Role Of B7 Family Members In The Generation Of Immunological Memory
Funder
National Health and Medical Research Council
Funding Amount
$437,252.00
Summary
Memory immune cells remember antigens that have previously induced an immune response. Therefore, they can react quickly and rigorously to stop subsequent infections. This project will study the role of the B7 family of proteins in communication between memory cells and other cells of the immune system to produce lifetime protection against foreign antigens. Understanding these processes will assist in creating more effective vaccines and treatments for immunodeficient or autoimmune patients.
Utilising Human Primary Immunodeficiencies To Study Lymphocyte Differentiation
Funder
National Health and Medical Research Council
Funding Amount
$429,346.00
Summary
Human immunodeficiencies are diseases arising from naturally occurring mutations. In this instance, the specific genes mutated in the immunodeficiencies we study have been identified. However, it is unclear how defects in these genes make an individual manifest as an immune deficient state, rendering them vulnerable to disease. By studying immune cells from these individuals we hope to uncover the normal function of these genes and subsequently provide for new therapies for these conditions.
Role Of The Novel G Protein-coupled Receptor EBI2 In B And T Cell Responses
Funder
National Health and Medical Research Council
Funding Amount
$304,815.00
Summary
The ability of the immune system to fight infections relies on the capacity of immune cells to traffic within immune organs in order to encounter invading pathogens and to interact with each other. Cells are guided in their migration by “homing receptors”, which recognize localization signals. This study aims at understanding the role of a novel member of this class of receptors, Epstein-Barr virus-induced gene 2 (EBI2), in the immune system and in protection against infectious microorganisms.